相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thalassemia 2016: Modern medicine battles an ancient disease
Deborah Rund
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Non-invasive prenatal diagnosis of β-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis
Mandana Zafari et al.
ANNALS OF HEMATOLOGY (2016)
New strategies to target iron metabolism for the treatment of beta thalassemia
Paraskevi Rea Oikonomidou et al.
COOLEY'S ANEMIA (2016)
A randomized trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major
Juliano L. Fernandes et al.
BLOOD (2016)
Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010
D. Baronciani et al.
BONE MARROW TRANSPLANTATION (2016)
Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the βA(T87Q)-Globin Gene
Olivier Negre et al.
HUMAN GENE THERAPY (2016)
Treating hemoglobinopathies using gene-correction approaches: promises and challenges
Renee N. Cottle et al.
HUMAN GENETICS (2016)
The mutual control of iron and erythropoiesis
C. Camaschella et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2016)
Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload
Yesim Aydinok et al.
BLOOD (2015)
Thalassemia major between liver and heart: Where we are now
Carlo Dessi et al.
BLOOD CELLS MOLECULES AND DISEASES (2015)
Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study
Yesim Aydinok et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients
Mohsen S. Elalfy et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia
Raffaella Origa et al.
HAEMATOLOGICA (2015)
Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia
Raffaella Origa et al.
HAEMATOLOGICA (2015)
Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia
Rajasekhar N. V. S. Suragani et al.
BLOOD (2014)
KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia
Dun Liu et al.
BLOOD (2014)
Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry
Caterina Borgna-Pignatti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase
Emanuela Ferru et al.
HAEMATOLOGICA (2014)
Modulators of Erythropoiesis Emerging Therapies for Hemoglobinopathies and Disorders of Red Cell Production
Laura Breda et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Updates of the HbVar database of human hemoglobin variants and thalassemia mutations
Belinda Giardine et al.
NUCLEIC ACIDS RESEARCH (2014)
Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients
Ali T. Taher et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach
Javid Gaziev et al.
BLOOD (2013)
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling
Franco Locatelli et al.
BLOOD (2013)
Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia
Khaled M. Musallam et al.
BLOOD (2013)
A national registry of haemoglobinopathies in Greece: Deducted demographics, trends in mortality and affected births
Ersi Voskaridou et al.
ANNALS OF HEMATOLOGY (2012)
Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications
Kallistheni Farmaki et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Optimal management of β thalassaemia intermedia
Ali T. Taher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
On T2*Magnetic Resonance and Cardiac Iron
John-Paul Carpenter et al.
CIRCULATION (2011)
Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia
Khaled M. Musallam et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Beta-thalassemia: from genotype to phenotype
Fabrice Danjou et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Combined iron chelation therapy
Renzo Galanello et al.
COOLEY'S ANEMIA: NINTH SYMPOSIUM (2010)
Progress in hematopoietic stem cell transplantation as allogeneic cellular gene therapy in thalassemia
Antonella Isgro et al.
COOLEY'S ANEMIA: NINTH SYMPOSIUM (2010)
Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study
Ali T. Taher et al.
BLOOD (2010)
Pregnancy and β-thalassemia: an Italian multicenter experience
Raffaella Origa et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
The Population Genetics and Dynamics of the Thalassemias
D. J. Weatherall et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Splenectomy and thrombosis: the case of thalassemia intermedia
A. T. Taher et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo et al.
NATURE (2010)
Beta-thalassemia
Renzo Galanello et al.
ORPHANET JOURNAL OF RARE DISEASES (2010)
Deferiprone Chelation Therapy for Thalassemia Major
R. Galanello et al.
ACTA HAEMATOLOGICA (2009)
Cardiac T2*Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major
P. Kirk et al.
CIRCULATION (2009)
Cholelithiasis in thalassemia major
Raffaella Origa et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Heart Disease in Thalassemia Intermedia
A. Aessopos et al.
HEMOGLOBIN (2009)
Glutathione S-transferase gene polymorphism and cardiac iron overload in thalassaemia major
R. Origa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Studies in haemoglobin E beta-thalassaemia
Nancy F. Olivieri et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Global epidemiology of haemoglobin disorders and derived service indicators
Bernadette Modell et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia
Raflaella Origa et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Once-daily oral deferasirox for the treatment of transfusional iron overload
Renzo Galanello et al.
Expert Review of Clinical Pharmacology (2008)
Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction
Mark A. Tanner et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2008)
Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance
Bernadette Modell et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2008)
Liver iron concentrations and urinary hepcidin in β-thalassemia
Raffaella Origa et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Thalassemia intermedia: Revisited
Ali Taher et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major
C Borgna-Pignatti et al.
BLOOD (2006)
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis
DJ Pennell et al.
BLOOD (2006)
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients
JC Wood et al.
BLOOD (2005)
Hepatocellular carcinoma in the thalassaemia syndromes
C Borgna-Pignatti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia
LJ Anderson et al.
LANCET (2002)
Screening for thalassemia - A model of success
A Cao et al.
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2002)
Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation
K Freson et al.
HUMAN MOLECULAR GENETICS (2002)
Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes
A Aessopos et al.
BLOOD (2002)
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
LJ Anderson et al.
EUROPEAN HEART JOURNAL (2001)
Mutations in the general transcription factor TFIIH result in β-thalassaemia in individuals with trichothiodystrophy
V Viprakasit et al.
HUMAN MOLECULAR GENETICS (2001)
Survival in β-thalassaemia major in the UK:: data from the UK thalassaemia register
B Modell et al.
LANCET (2000)
分享论文
